GenVec (GNVC)
GenVec Capital Expenditures: 0.064M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
GNVC Capital Expenditures Rankings
| Overall | 74th percentile | 1148 of 4449 |
| Sector | 64th percentile | 179 of 507 in Healthcare |
| Industry | 53rd percentile | 73 of 158 in Biotechnology |
GNVC Capital Expenditures Range, Past 5 Years
| Minimum | 0.00 | Mar 2009 |
| Maximum | 0.206M | Jun 2010 |
| Average | 0.0708M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these GNVC related companies
GNVC News
GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
May 03, 8:30AM PR Newswire
May 03, 8:30AM PR Newswire
Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against GenVec, Inc.
Jan 10, 3:52PM Business Wire
Jan 10, 3:52PM Business Wire
GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011
Nov 02, 8:40AM PR Newswire
Nov 02, 8:40AM PR Newswire
$GNVC http://stks.co/Axr trying to sneak out here. Sneak sneak sneak.
about 261 days ago by retailtrader
about 261 days ago by retailtrader
In LiveCharts today, we analyzed the charts on $MOTR $UCO $DF $AAPL $SPY $LLNW KKD $GNVC $HSOL and REMX http://stk.ly/mpKIaS
about 341 days ago by SharePlanner
about 341 days ago by SharePlanner
$LPX Buying trigger : $8.04 Profit: 1.8% $GNVC Buying Trigger: $ 3.11 Profit : 4.5% $LAVA Buying Trigger $7.90 Profit: 2.27%
about 342 days ago by Trade4Me
about 342 days ago by Trade4Me
$GNVC Buying Trigger: $ 3.11 Volume change: 137% Earnings Growth: 56% Revenue Growth 82%
about 343 days ago by Trade4Me
about 343 days ago by Trade4Me
Watch List : $LAVA Buying Trigger $ 7.90 $BJRI Buying Trigger: $ 48.31 $GNVC Buying Trigger: $ 3.11
about 343 days ago by Trade4Me
about 343 days ago by Trade4Me
RT @adamfeuerstein Other bio-shells available for reverse mergers -- $TELK, $GNVC (h/t @LTbioinvestor)
about 351 days ago by chicagosean
about 351 days ago by chicagosean
$GNVC GenVec Technology Used To Restore Lost Balance Function http://stk.ly/haJmMo
about 415 days ago by mike_peace
about 415 days ago by mike_peace
$gnvc something happening, nice volume and breakout on a weak tape. risky tho
about 496 days ago by mike_peace
about 496 days ago by mike_peace
nibbled at some $GNVC today....because ya never know when a spike can occurr
about 497 days ago by beachlife
about 497 days ago by beachlife
my watchlist for week 17-21 January 2011 http://stk.ly/hPSzN9 $SOL $PTIE $ENMD $GNVC $X $MOTR $FORM
about 499 days ago by mike_peace
about 499 days ago by mike_peace
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GNVC | 2.52 | +0.02 | +0.80% | 32.40M |
| GNTX | 23.07 | +0.50 | +2.22% | 3.253B |
| GNRC | 25.39 | +0.13 | +0.51% | 1.715B |
| GNOM | 2.61 | -0.39 | -13.00% | 100.26M |
| GNMK | 4.61 | +0.03 | +0.66% | 93.89M |
| GNK | 3.23 | +0.01 | +0.31% | 141.07M |
| GNI | 65.28 | +2.39 | +3.80% | 94.34M |
| GNE | 7.07 | +0.06 | +0.86% | |
| GNCMA | 6.33 | -0.36 | -5.38% | 295.30M |
| GNC | 39.54 | -0.01 | -0.03% |
